Novartis AG 2014 AR2
The report highlights Novartis' strong performance in 2014, during which the company initiated a major portfolio transformation to focus on its three leading divisions: Pharmaceuticals, Alcon, and Sandoz. Financially, the company achieved net sales of USD 58.0 billion and a core operating income of USD 14.6 billion. In terms of innovation, Novartis secured 13 major approvals in key markets and advanced its pipeline with promising treatments like LCZ696 for heart failure. On the sustainability front, the company expanded healthcare access to 72 million patients through various programs and continued its efforts to reduce greenhouse gas emissions and improve environmental sustainability.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2014
Type: AR2
Pages: 248
Back to company
Novartis AG
Annual Report
The report highlights Novartis' strong performance in 2014, during which the company initiated a major portfolio transformation to focus on its three leading divisions: Pharmaceuticals, Alcon, and Sandoz. Financially, the company achieved net sales of USD 58.0 billion and a core operating income of USD 14.6 billion. In terms of innovation, Novartis secured 13 major approvals in key markets and advanced its pipeline with promising treatments like LCZ696 for heart failure. On the sustainability front, the company expanded healthcare access to 72 million patients through various programs and continued its efforts to reduce greenhouse gas emissions and improve environmental sustainability.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 2:
Energy Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees